Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
A majority of K Street leaders say artificial intelligence regulation should primarily be handled at the federal level by Congress.

K Street believes in federal AI regulation

A majority of K Street leaders say artificial intelligence regulation should primarily be handled at the federal level by Congress, according to our latest Canvass results.

More Republicans (79%) than Democrats (60%)shared the sentiment that AI should be federally regulated.

President Donald Trump has sought to restrict state laws related to AI, while instead setting a national standard for the technology.

The White House released a proposal in March for federal regulation of AI that would overrule most state policymaking. The proposal also seeks to protect young people, creators, political speech and local governments that want to make their own decisions on data centers.

Democrats say the proposal doesn’t do enough for workers at risk of losing their jobs as AI advances while letting the industry off the hook. Top Republicans acknowledged it will be difficult for Congress to enact comprehensive AI regulation this year.

Republicans generally have supported Trump’s desire to focus on a national framework. On Capitol Hill, Democrats want states to have a robust consumer-protection role alongside the federal government. But on K Street, the majority of Democrats still focused on uniform rules.

The Canvass K Street was conducted March 2-20 in partnership with independent public affairs firm, LSG.

Want to take part in The Canvass? Our survey provides anonymous monthly insights from top Capitol Hill staffers and K Street leaders on key issues facing Washington.

Don’t miss out on your chance to weigh in! Sign up here if you work on K Street. Click here to sign up if you’re a senior congressional staffer.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.